Eur Rev Med Pharmacol Sci 2020; 24 (24): 12971-12977

DOI: 10.26355/eurrev_202012_24201

Gut microbiota and its metabolic potential

A. Czajkowska, K. Kaźmierczak-Siedlecka, D. Jamioł-Milc, I. Gutowska, K. Skonieczna-Żydecka

Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, Szczecin, Poland. leokadia@gumed.edu.pl


OBJECTIVE: The incidence of obesity and other metabolic-related diseases has been gradually increasing. Multiple genetic as well as environmental factors play a significant role in the pathogenesis of these entities. Currently, the involvement of gut microbiota in metabolic processes has been acknowledged. This paper focuses on obesity, type 2 diabetes, and nonalcoholic fatty liver disease regarding their link with microbiome structure and its function.

MATERIALS AND METHODS: We analyzed literature available in PubMed, Embase, and Google Scholar databases regarding a linkage of metabolic-associated diseases and gut microbiota

RESULTS: Gut microbiota plays a significant role in host metabolism. Depending on its composition; however, it may contribute to the development of metabolic-associated diseases. In this context, not only composition of gut microbiota is important, but also its activity. Short-chain fatty acids or lipopolysaccharides are crucial metabolites involved in maintaining metabolic balance.

CONCLUSIONS: Gut microbiota malfunctions might potentially induce obesity, type 2 diabetes, and nonalcoholic fatty liver disease.

Free PDF Download

To cite this article

A. Czajkowska, K. Kaźmierczak-Siedlecka, D. Jamioł-Milc, I. Gutowska, K. Skonieczna-Żydecka
Gut microbiota and its metabolic potential

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 24
Pages: 12971-12977
DOI: 10.26355/eurrev_202012_24201